On June 27, 2019, Intersect ENT, Inc. announced that Thomas A. West has been appointed as the Company's new President and Chief Executive Officer, effective July 22, 2019, and in that role will be the Company's principal executive officer. On the Commencement Date, Kieran T. Gallahue, the Company's Interim Chief Executive Officer and Executive Chairman of the Board of Directors of the Company, will cease to be the Company's principal executive officer and will remain the Executive Chairman of the Board of Directors of the Company. Mr. West, age 55, has served as division president, diagnostics at Hologic Inc. since October 2014.

From 1992 to 2014, Mr. West worked at Johnson & Johnson in various roles of increasing responsibility. Most recently, he served as the Worldwide Vice President – Strategy and Business Development for Johnson & Johnson's Diabetes Solutions Companies, in which role he was responsible for business strategy and development initiatives across all markets. Prior to 1992, he served as President of LifeScan North America and as President of LifeScan EMEA.

On June 27, 2019, the Company announced that Jeryl L. Hilleman, Chief Financial Officer, will resign from the Company effective as of early 2020, to focus on serving on boards of directors of other companies.